TY - JOUR
T1 - Hypercalcemia in acute uremia and following citric acid administration
T2 - Differential effect on parathyroid gland microtubule content
AU - Reaven, Gerald M.
AU - Reaven, Peter D.
AU - Reaven, Eve P.
N1 - Funding Information:
From the Department of Medicine, Stanford University School of Medicine and Yeterans Administration Hospital, Palo Alto. Calif Received for publication May 9.1975. Supported by funds from the Veterans Administration. Reprint request should be addressed to Gerald M. Reaven, M.D.. Veterans Administration Hospital, 3801 Miranda Avenue, Palo Alto, Calif 94304. 0 1976 by Gnme & Stratton, Inc.
PY - 1976/2
Y1 - 1976/2
N2 - Hypercalcemia, which occurs 4 hr after bilateral nephrectomy in normal rats, is not seen 4 hr after either bilateral ureterotomy or sham surgery. These results indicate that it is loss of renal mass per se, not the uremic syndrome, which is responsible for the hypercalcemia. Citric acid levels also increase 4 hr after nephrectomy, and a degree of hypercalcemia and hypercitricemia comparable to that which follows nephrectomy can be produced by administration of citric acid to normal rats. In an attempt to evaluate the role of the parathyroid gland in the development of hypercalcemia in these two situations, the microtubule content of parathyroid gland chief cells was determined by ultrastructural stereologic techniques 4 hr after either bilateral nephrectomy or citric acid administration. The results of these measurements indicate that parathyroid gland chief cell microtubule content increases after citric acid administration but not following bilateral nephrectomy. The significance of these results is not clear. However, since a previous study has suggested a correlation between increased microtubule content and increased secretory status in the chief cell, one may speculate that increased microtubule content resulting from citric acid administration may also be associated with increased parathyroid hormone secretion. By this formulation, citric acid-induced hypercalcemia would be secondary to increased parathyroid hormone secretion, but the transient hypercalcemia that occurs after nephrectomy would take place in the absence of an increase in parathyroid hormone secretion. In this latter instance, it is possible that loss of the kidney, a major site of parathyroid hormone removal from plasma, leads to an increase in circulating parathyroid hormone level, and hypercalcemia, in the absence of an increase in hormone secretion rate.
AB - Hypercalcemia, which occurs 4 hr after bilateral nephrectomy in normal rats, is not seen 4 hr after either bilateral ureterotomy or sham surgery. These results indicate that it is loss of renal mass per se, not the uremic syndrome, which is responsible for the hypercalcemia. Citric acid levels also increase 4 hr after nephrectomy, and a degree of hypercalcemia and hypercitricemia comparable to that which follows nephrectomy can be produced by administration of citric acid to normal rats. In an attempt to evaluate the role of the parathyroid gland in the development of hypercalcemia in these two situations, the microtubule content of parathyroid gland chief cells was determined by ultrastructural stereologic techniques 4 hr after either bilateral nephrectomy or citric acid administration. The results of these measurements indicate that parathyroid gland chief cell microtubule content increases after citric acid administration but not following bilateral nephrectomy. The significance of these results is not clear. However, since a previous study has suggested a correlation between increased microtubule content and increased secretory status in the chief cell, one may speculate that increased microtubule content resulting from citric acid administration may also be associated with increased parathyroid hormone secretion. By this formulation, citric acid-induced hypercalcemia would be secondary to increased parathyroid hormone secretion, but the transient hypercalcemia that occurs after nephrectomy would take place in the absence of an increase in parathyroid hormone secretion. In this latter instance, it is possible that loss of the kidney, a major site of parathyroid hormone removal from plasma, leads to an increase in circulating parathyroid hormone level, and hypercalcemia, in the absence of an increase in hormone secretion rate.
UR - http://www.scopus.com/inward/record.url?scp=0017290171&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017290171&partnerID=8YFLogxK
U2 - 10.1016/0026-0495(76)90050-0
DO - 10.1016/0026-0495(76)90050-0
M3 - Article
C2 - 1250158
AN - SCOPUS:0017290171
SN - 0026-0495
VL - 25
SP - 203
EP - 209
JO - Metabolism
JF - Metabolism
IS - 2
ER -